These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of Diosmin and Flavin Adenine Dinucleotide as Repurposing Treatments for Monkeypox Virus: A Computational Study. Lam TP; Tran VH; Mai TT; Lai NV; Dang BN; Le MT; Tran TD; Trinh DT; Thai KM Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232872 [TBL] [Abstract][Full Text] [Related]
3. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002 [TBL] [Abstract][Full Text] [Related]
5. Identifying potential monkeypox virus inhibitors: an Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508 [TBL] [Abstract][Full Text] [Related]
6. Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study. Preet G; Oluwabusola ET; Milne BF; Ebel R; Jaspars M Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430762 [TBL] [Abstract][Full Text] [Related]
7. Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach. Dutt M; Kumar A; Rout M; Dehury B; Martinez G; Ndishimye P; Kelvin AA; Kelvin DJ J Cell Biochem; 2023 May; 124(5):701-715. PubMed ID: 36946432 [TBL] [Abstract][Full Text] [Related]
11. Bioprospecting of Meliaceae family phytomolecules for the treatment of monkeypox virus infection: a QSAR modeling and MD simulation approach. Rabaan AA; Halwani MA; Alshehri AA; Al-Subaie MF; Almansour ZH; AlShehail BM; Alotaibi N; Khamis F; Al Kaabi NA; Alsomali G; Alqahtani AS; Alissa M J Biomol Struct Dyn; 2024 Jan; ():1-23. PubMed ID: 38174404 [TBL] [Abstract][Full Text] [Related]
12. Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I. Hu X; An S; Chu J; Liang B; Liao Y; Jiang J; Lin Y; Ye L; Liang H Molecules; 2023 Feb; 28(3):. PubMed ID: 36771105 [TBL] [Abstract][Full Text] [Related]
13. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus. Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340 [TBL] [Abstract][Full Text] [Related]
15. Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches. Rehman HM; Sajjad M; Ali MA; Gul R; Naveed M; Aslam MS; Shinwari K; Bhinder MA; Ghani MU; Saleem M; Rather MA; Ahmad I; Amin A Int J Biol Macromol; 2023 May; 237():124169. PubMed ID: 36990409 [TBL] [Abstract][Full Text] [Related]
16. Natural photosensitizers potentiate the targeted antimicrobial photodynamic therapy as the Monkeypox virus entry inhibitors: An in silico approach. Pourhajibagher M; Bahador A Photodiagnosis Photodyn Ther; 2023 Sep; 43():103656. PubMed ID: 37336465 [TBL] [Abstract][Full Text] [Related]
17. A systematic drug repurposing approach to identify promising inhibitors from FDA-approved drugs against Nsp4 protein of SARS-CoV-2. Chakraborty J; Maity A; Sarkar H J Biomol Struct Dyn; 2023 Feb; 41(2):550-559. PubMed ID: 34844509 [TBL] [Abstract][Full Text] [Related]